Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$232.24 - $267.23 $18,579 - $21,378
80 Added 5.52%
1,529 $372,000
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $26,254 - $29,209
103 Added 7.65%
1,449 $374,000
Q2 2023

Aug 10, 2023

BUY
$238.39 - $265.32 $3,337 - $3,714
14 Added 1.05%
1,346 $355,000
Q1 2023

May 12, 2023

BUY
$229.71 - $259.35 $7,121 - $8,039
31 Added 2.38%
1,332 $329,000
Q4 2022

Feb 01, 2023

SELL
$218.29 - $256.91 $3,492 - $4,110
-16 Reduced 1.21%
1,301 $330,000
Q3 2022

Jan 27, 2023

BUY
$51.03 - $264.23 $6,889 - $35,671
135 Added 11.42%
1,317 $294,000
Q3 2022

Oct 20, 2022

BUY
$51.03 - $264.23 $6,889 - $35,671
135 Added 11.42%
1,317 $294,000
Q2 2022

Jan 27, 2023

BUY
$234.74 - $275.42 $32,159 - $37,732
137 Added 13.11%
1,182 $291,000
Q2 2022

Aug 15, 2022

BUY
$234.74 - $275.42 $32,159 - $37,732
137 Added 13.11%
1,182 $291,000
Q1 2022

Jan 27, 2023

BUY
$243.64 - $270.48 $12,425 - $13,794
51 Added 5.13%
1,045 $278,000
Q1 2022

May 04, 2022

BUY
$243.64 - $270.48 $12,425 - $13,794
51 Added 5.13%
1,045 $278,000
Q4 2021

Jan 27, 2023

SELL
$230.08 - $250.94 $28,069 - $30,614
-122 Reduced 10.93%
994 $250,000
Q4 2021

Feb 11, 2022

SELL
$230.08 - $250.94 $28,069 - $30,614
-122 Reduced 10.93%
994 $250,000
Q3 2021

Jan 27, 2023

BUY
$232.72 - $256.47 $29,788 - $32,828
128 Added 12.96%
1,116 $274,000
Q3 2021

Nov 15, 2021

BUY
$232.72 - $256.47 $29,788 - $32,828
128 Added 12.96%
1,116 $274,000
Q2 2021

Jan 27, 2023

SELL
$232.65 - $254.58 $76,541 - $83,756
-329 Reduced 24.98%
988 $240,000
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $229,858 - $251,525
988 New
988 $240,000
Q2 2020

Aug 17, 2020

SELL
$219.9 - $263.41 $201,428 - $241,283
-916 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$195.69 - $279.01 $179,252 - $255,573
916 New
916 $211,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.